Reduced expression of metabotropic glutamate receptor 2mRNA in T cells of ALS patients

Annals of Neurology

Volumn 58, Issue 6, 2005, Pages 946-949

  Poulopoulou, Cornelia ^a   Davaki, Panagiota ^a   Koliaraki, Vassiliki ^a   Kolovou, Dimitra ^a   Markakis, Ioannis ^a   Vassilopoulos, Dimitrios ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; METABOTROPIC RECEPTOR 2; RILUZOLE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXCITOTOXICITY; FEMALE; HUMAN; HUMAN CELL; MALE; NERVE CELL EXCITABILITY; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; GENE EXPRESSION; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, METABOTROPIC GLUTAMATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 28544440970     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20675     Document Type: Article

References (17)

1. Heath PR, Shaw PJ. Update on the glutamatergic neurotransmitter system and the role of excitoxicity in amyotrophic lateral sclerosis. Muscle Nerve 2002;26:438-458.
2. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992;326:1464-1468.
3. Bensimon G, Lacomblez L, Meininder V, and the ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994;330:585-591.
4. Pizzi M, Benarese M, Boroni F, et al. Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat. Neuropharmacology 2000;39:903-910.
5. Aronica E, Catania EM, Geurts J, et al. Immunohistochemical localization of group I and group II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. Neuroscience 2001;105:509-520.
6. Hinoi E, Takarada T, Ueshima T, et al. Glutamate signaling in peripheral tissues. Eur J Biochem 2004;271:1-13.
7. Storto M, de Grazia U, Battaglia G, et al. Expression of metabotropic glutamate receptors in murine thymocytes and thymic stromal cells. J Neuroimmunol 2000;109:112-120.
8. Pacheso R, Ciruela F, Casado V, et al. Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation. J Biol Chem 2004;32:33352-33358.
9. Poulopoulou C, Markakis I, Davaki P, et al. Modulation of voltage-gated potassium channels in human T-lymphocytes by extracellular glutamate. Mol Pharmacol 2005;67:856-867.
10. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of World Federation of Neurology Research Group on Neuromuscular Diseases and El Escorial "Clinical Limits of Amyotrophic Lateral Sclerosis" Workshop contributors. El Escorial World Federation of Neurology research criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994; 124(suppl):96-107.
11. Cedarbaum JM, Stambler N. Performance of the amyotrophic lateral sclerosis functional rating scale (ALSFRS) in multicenter clinical trials. J Neurol Sci 1997;152(suppl 1):1-8.
12. Plaitakis A, Caroscio JT. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol 1986;22:446-449.
13. Ferrarese C, Sala G, Riva R, et al. Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology 2001;56:270-272.
14. Ishida M, Saitoh T, Shimamoto K, et al. A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord. Br J Pharmacol 1993;109:1169-1177.
15. Cohn PJ, Pin JP. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997;37: 205-237.
16. Messenger MJ, Dawson LG, Duty S. Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract. Neuropharmacology 2002;43:261-271.
17. Ferri A, Nencini M, Battistini S, et al. Activity of protein phosphatase calcineurin is decreased in sporadic and familial amyotrophic lateral sclerosis patients. J Neurochem 2004;90: 1237-1242.